Hospital reception area (representational image)Representational image of a hospital reception area.

New Delhi, November 15: Government spending on health in India has more than tripled in ten years, while the share of health costs that families pay out of their own pockets has fallen sharply, according to the National Health Accounts (NHA) estimates for 2023-24 released by the Union Health Ministry on Sunday.

The estimates show government health expenditure rising from ₹1,29,778 crore in 2013-14 to ₹4,14,196 crore in 2023-24. Over the same period, out-of-pocket expenditure fell from 64.2 per cent of total health spending to 42.7 per cent, a drop of 21.5 percentage points. The ministry said the share was 43.4 per cent in 2022-23, so the decline continued in the latest year.

Public spending per person

Government health spending per person rose from ₹1,042 to ₹2,959, about 2.8 times. The government’s share of total health expenditure went up by 14.9 percentage points over the decade, the ministry said.

Primary care and insurance

Government spending on primary healthcare reached about ₹1.53 lakh crore. The ministry linked this to the expansion of Ayushman Arogya Mandirs, which offer preventive care, screening for non-communicable diseases, essential medicines and diagnostics.

Social security spending on health, which covers Ayushman Bharat PM-JAY, state insurance schemes, social health insurance and medical expenses of government employees, rose from 6 per cent of total health spending in 2013-14 to 11 per cent in 2023-24. Private health insurance spending also grew, from 3.4 per cent to 10.2 per cent.

Schemes the ministry cites

The ministry pointed to the free drugs and diagnostics initiative, the Pradhan Mantri National Dialysis Programme, the Pradhan Mantri Bhartiya Janaushadhi Pariyojana and AMRIT pharmacies as measures that make medicines and treatment cheaper. It also named cashless hospital admission under Ayushman Bharat PM-JAY and drug price regulation by the National Pharmaceutical Pricing Authority, which recently capped trade margins on 137 anti-cancer drugs.

About the estimates

The 2023-24 figures are the eleventh round of estimates prepared by the National Health Accounts Technical Secretariat at the National Health Systems Resource Centre, which works under the Health Ministry. They follow the System of Health Accounts 2011 framework. The full estimates are available on the NHSRC website.

Leave a Reply

Your email address will not be published. Required fields are marked *